Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
62.19
-0.08 (-0.13%)
At close: Mar 5, 2026, 4:00 PM EST
61.75
-0.44 (-0.71%)
Pre-market: Mar 6, 2026, 8:04 AM EST
Cytokinetics Analyst Ratings
Total Analysts
18
Consensus Rating
Strong Buy
Price Target
$86.00
Upside
+38.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $83 → $84 | Buy | Maintains | $83 → $84 | +35.07% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $88 → $96 | Buy | Maintains | $88 → $96 | +54.37% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $84 → $85 | Strong Buy | Maintains | $84 → $85 | +36.68% | Feb 25, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $95 → $101 | Buy | Maintains | $95 → $101 | +62.41% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $84 → $92 | Strong Buy | Maintains | $84 → $92 | +47.93% | Feb 3, 2026 |
| Barclays | Barclays | Buy Initiates $87 | Buy | Initiates | $87 | +39.89% | Jan 28, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $90 → $108 | Strong Buy | Maintains | $90 → $108 | +73.66% | Jan 21, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +52.76% | Jan 21, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $70 → $74 | Buy | Maintains | $70 → $74 | +18.99% | Jan 20, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $71 | Buy | Maintains | $65 → $71 | +14.17% | Dec 23, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $87 → $95 | Buy | Maintains | $87 → $95 | +52.76% | Dec 22, 2025 |
| Barclays | Barclays | Buy Maintains $82 → $87 | Buy | Maintains | $82 → $87 | +39.89% | Dec 22, 2025 |
| Citizens | Citizens | Buy Maintains $78 → $88 | Buy | Maintains | $78 → $88 | +41.50% | Dec 22, 2025 |
| Needham | Needham | Strong Buy Maintains $72 → $84 | Strong Buy | Maintains | $72 → $84 | +35.07% | Dec 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $136 | Strong Buy | Maintains | $120 → $136 | +118.68% | Dec 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $55 → $95 | Hold → Strong Buy | Upgrades | $55 → $95 | +52.76% | Dec 19, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.